$8.32
0.699.04%
At Close: -
$8.29
-0.03-0.36%
After Hours: 4:58 PM EDT
15 minutes delayed
XPeng
XPEVNYSE
XPeng (NYSE:XPEV) 주식, 분석가 평가, 목표 가격, 예측
XPeng Inc has a consensus price target of $15.86, established from looking at the 50 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, Macquarie, and Morgan Stanley on June 25, 2024, April 15, 2024, and March 11, 2024. With an average price target of $11.1 between Citigroup, Macquarie, and Morgan Stanley, there's an implied 33.41% upside for XPeng Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Macquarie
Morgan Stanley
JP Morgan
Barclays
1calculated from analyst ratings
Analyst Ratings for XPeng
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | Buy Now | -0.24% | Citigroup | Jeff Chung | $7.7 → $8.3 | Upgrade | Sell → Neutral | Get Alert |
| 04/15/2024 | Buy Now | -15.87% | Macquarie | Eugene Hsiao | → $7 | Reinstates | → Neutral | Get Alert |
| 03/11/2024 | Buy Now | 116.35% | Morgan Stanley | Tim Hsiao | $23.1 → $18 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 8.17% | JP Morgan | Nick Lai | $19 → $9 | Maintains | Neutral | Get Alert |
| 09/22/2023 | Buy Now | 205.29% | Morgan Stanley | Tim Hsiao | $25.4 → $25.4 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | -3.85% | Barclays | Jiong Shao | $6 → $8 | Maintains | Underweight | Get Alert |
| 08/21/2023 | Buy Now | 92.31% | JP Morgan | Nick Lai | $18 → $16 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | 164.42% | B of A Securities | Ming Hsun Lee | $16.3 → $22 | Upgrade | Neutral → Buy | Get Alert |
| 08/08/2023 | Buy Now | 188.46% | CLSA | Ding Luo | → $24 | Upgrade | Outperform → Buy | Get Alert |
| 08/07/2023 | Buy Now | 164.42% | HSBC | Yuqian Ding | → $22 | Upgrade | Hold → Buy | Get Alert |
| 08/02/2023 | Buy Now | 80.29% | Citigroup | Jeff Chung | $6.28 → $15 | Maintains | Sell | Get Alert |
| 07/31/2023 | Buy Now | 176.44% | UBS | Paul Gong | → $23 | Downgrade | Buy → Neutral | Get Alert |
| 07/28/2023 | Buy Now | 204.09% | Jefferies | Johnson Wan | $7.8 → $25.3 | Upgrade | Hold → Buy | Get Alert |
| 07/21/2023 | Buy Now | 20.19% | JP Morgan | Nick Lai | $7.5 → $10 | Downgrade | Neutral → Underweight | Get Alert |
| 07/11/2023 | Buy Now | — | Goldman Sachs | Tina Hou | → $18.1 | Initiates | → Buy | Get Alert |
| 07/07/2023 | Buy Now | 26.2% | BOCOM International | Angus Chan | → $10.5 | Downgrade | Neutral → Sell | Get Alert |
| 06/30/2023 | Buy Now | 57.45% | CLSA | Ding Luo | $10 → $13.1 | Upgrade | Buy → Outperform | Get Alert |
| 06/16/2023 | Buy Now | 40.62% | B of A Securities | Ming Hsun Lee | $9.8 → $11.7 | Maintains | Neutral | Get Alert |
| 05/25/2023 | Buy Now | 17.79% | B of A Securities | Ming Hsun Lee | $11 → $9.8 | Maintains | Neutral | Get Alert |
| 05/25/2023 | Buy Now | -27.88% | Barclays | Jiong Shao | $8 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 04/25/2023 | Buy Now | 11.78% | Jefferies | Johnson Wan | $4.2 → $9.3 | Upgrade | Underperform → Hold | Get Alert |
| 03/24/2023 | Buy Now | 44.23% | Bernstein | Eunice Lee | $16 → $12 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/18/2023 | Buy Now | 28.61% | B of A Securities | Ming Hsun Lee | $11 → $10.7 | Maintains | Neutral | Get Alert |
| 01/11/2023 | Buy Now | 8.17% | JP Morgan | Nick Lai | $11 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | — | B of A Securities | Ming Hsun Lee | — | Downgrade | Buy → Neutral | Get Alert |
| 12/14/2022 | Buy Now | -3.85% | Daiwa Capital | Kelvin Lau | $13 → $8 | Downgrade | Buy → Sell | Get Alert |
| 12/13/2022 | Buy Now | 80.29% | HSBC | Yuqian Ding | $34 → $15 | Maintains | Buy | Get Alert |
| 12/02/2022 | Buy Now | 35.82% | China Renaissance | Yiming Wang | $40.5 → $11.3 | Downgrade | Buy → Hold | Get Alert |
| 11/28/2022 | Buy Now | -49.52% | Jefferies | Johnson Wan | $18.6 → $4.2 | Downgrade | Hold → Underperform | Get Alert |
| 11/17/2022 | Buy Now | 56.25% | UBS | Paul Gong | $34 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 10/28/2022 | Buy Now | -61.78% | Citigroup | Jeff Chung | → $3.18 | Downgrade | Buy → Sell | Get Alert |
| 10/28/2022 | Buy Now | -3.85% | Barclays | Jiong Shao | $22 → $8 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | Buy Now | 234.98% | Citigroup | Jeff Chung | $51.59 → $27.87 | Maintains | Buy | Get Alert |
| 08/24/2022 | Buy Now | 164.42% | Barclays | Jiong Shao | $30 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 200.48% | Macquarie | Erica Chen | → $25 | Downgrade | Outperform → Neutral | Get Alert |
| 07/01/2022 | Buy Now | 336.3% | Nomura Instinet | Martin Heung | → $36.3 | Downgrade | Buy → Neutral | Get Alert |
| 06/21/2022 | Buy Now | 520.07% | Citigroup | Jeff Chung | $36.7 → $51.59 | Maintains | Buy | Get Alert |
| 05/24/2022 | Buy Now | 320.67% | JP Morgan | Nick Lai | $42 → $35 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | 260.58% | Barclays | Jiong Shao | $39 → $30 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | 380.77% | B of A Securities | Ming Hsun Lee | $46 → $40 | Maintains | Buy | Get Alert |
| 03/29/2022 | Buy Now | 705.29% | Citigroup | Jeff Chung | $92 → $67 | Maintains | Buy | Get Alert |
| 03/29/2022 | Buy Now | 368.75% | Barclays | Jiong Shao | $45 → $39 | Maintains | Overweight | Get Alert |
| 03/24/2022 | Buy Now | 568.27% | China Renaissance | Yiming Wang | → $55.6 | Initiates | → Buy | Get Alert |
| 03/23/2022 | Buy Now | — | CLSA | Ding Luo | — | Initiates | → Buy | Get Alert |
| 03/23/2022 | Buy Now | 404.81% | Morgan Stanley | Tim Hsiao | $71 → $42 | Maintains | Overweight | Get Alert |
| 02/08/2022 | Buy Now | — | Barclays | Jiong Shao | — | Initiates | → Overweight | Get Alert |
| 01/12/2022 | Buy Now | — | Macquarie | Erica Chen | — | Initiates | → Outperform | Get Alert |
| 11/24/2021 | Buy Now | 693.27% | B of A Securities | Ming Hsun Lee | — | Maintains | Buy | Get Alert |
| 10/28/2021 | Buy Now | 573.08% | Bernstein | Eunice Lee | — | Initiates | → Outperform | Get Alert |
| 08/27/2021 | Buy Now | 633.17% | B of A Securities | Ming Hsun Lee | $56 → $61 | Maintains | Buy | Get Alert |
FAQ
What is the target price for XPeng (XPEV) stock?
The latest price target for XPeng (NYSE:XPEV) was reported by Citigroup on June 25, 2024. The analyst firm set a price target for $8.30 expecting XPEV to rise to within 12 months (a possible 0.12% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for XPeng (XPEV)?
The latest analyst rating for XPeng (NYSE:XPEV) was provided by Citigroup, and XPeng upgraded their neutral rating.
When was the last upgrade for XPeng (XPEV)?
The last upgrade for XPeng Inc happened on June 25, 2024 when Citigroup raised their price target to $8.3. Citigroup previously had a sell for XPeng Inc.
When was the last downgrade for XPeng (XPEV)?
The last downgrade for XPeng Inc happened on July 31, 2023 when UBS changed their price target from N/A to $23 for XPeng Inc.
When is the next analyst rating going to be posted or updated for XPeng (XPEV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XPeng, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XPeng was filed on June 25, 2024 so you should expect the next rating to be made available sometime around June 25, 2025.
Is the Analyst Rating XPeng (XPEV) correct?
While ratings are subjective and will change, the latest XPeng (XPEV) rating was a upgraded with a price target of $7.70 to $8.30. The current price XPeng (XPEV) is trading at is $8.29, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.